[go: up one dir, main page]

DK150302C - METHOD OF ANALOGUE FOR THE PREPARATION OF SPIRO-HYDANTOIN COMPOUNDS OR PHARMACOLOGICAL ACCEPTABLE BASES - Google Patents

METHOD OF ANALOGUE FOR THE PREPARATION OF SPIRO-HYDANTOIN COMPOUNDS OR PHARMACOLOGICAL ACCEPTABLE BASES

Info

Publication number
DK150302C
DK150302C DK461377A DK461377A DK150302C DK 150302 C DK150302 C DK 150302C DK 461377 A DK461377 A DK 461377A DK 461377 A DK461377 A DK 461377A DK 150302 C DK150302 C DK 150302C
Authority
DK
Denmark
Prior art keywords
spiro
analogue
preparation
acceptable bases
hydantoin compounds
Prior art date
Application number
DK461377A
Other languages
Danish (da)
Other versions
DK461377A (en
DK150302B (en
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer filed Critical Pfizer
Publication of DK461377A publication Critical patent/DK461377A/en
Publication of DK150302B publication Critical patent/DK150302B/en
Application granted granted Critical
Publication of DK150302C publication Critical patent/DK150302C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK461377A 1976-10-18 1977-10-17 METHOD OF ANALOGUE FOR THE PREPARATION OF SPIRO-HYDANTOIN COMPOUNDS OR PHARMACOLOGICAL ACCEPTABLE BASES DK150302C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US73306276 1976-10-18
US76780377 1977-02-11
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (3)

Publication Number Publication Date
DK461377A DK461377A (en) 1978-04-19
DK150302B DK150302B (en) 1987-02-02
DK150302C true DK150302C (en) 1987-09-28

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
DK461377A DK150302C (en) 1976-10-18 1977-10-17 METHOD OF ANALOGUE FOR THE PREPARATION OF SPIRO-HYDANTOIN COMPOUNDS OR PHARMACOLOGICAL ACCEPTABLE BASES

Country Status (29)

Country Link
JP (3) JPS5353653A (en)
AR (1) AR220901A1 (en)
AT (1) AT356136B (en)
AU (1) AU504978B2 (en)
BG (1) BG28847A3 (en)
CA (1) CA1088945A (en)
CH (1) CH625511A5 (en)
DD (1) DD131931A5 (en)
DE (4) DE2759927C2 (en)
DK (1) DK150302C (en)
ES (1) ES463267A1 (en)
FI (1) FI62307C (en)
FR (1) FR2367754A1 (en)
GB (1) GB1566171A (en)
GR (1) GR70201B (en)
HK (1) HK53881A (en)
IE (1) IE45805B1 (en)
IL (1) IL53094A0 (en)
KE (1) KE3167A (en)
LU (1) LU78330A1 (en)
MX (1) MX4899E (en)
MY (1) MY8200157A (en)
NL (1) NL167434C (en)
NO (1) NO148453C (en)
NZ (1) NZ185358A (en)
PH (1) PH15639A (en)
PT (1) PT67164B (en)
SE (1) SE437024B (en)
YU (1) YU40821B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (en) * 1982-01-20 1983-12-12 Eisai Co Ltd Remedy containing hydantoin derivative
JPS59500617A (en) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド Hydantoin therapeutic agent
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (en) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk Novel spiro-3-heteroazolidine compound, production thereof, preventive and remedy for diabetic complication comprising same as active ingredient
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (en) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd Hydantoin derivative, salt and, production thereof and preventing and treating, agent for diabetic complication
MX12896A (en) * 1987-09-04 1993-06-01 Pfizer PROCEDURE FOR PREPARING A SPYRO-HETEROAZOLON COMPOUND
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
CA2482035A1 (en) * 2002-04-18 2003-10-30 University Of Virginia Patent Foundation Novel sodium channel blockers
FR2955107B1 (en) 2010-01-08 2012-03-02 Servier Lab NOVEL THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (en) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Process for the production of new, anticonvulsant spirohydantoins
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (en) * 1974-10-11 1976-05-20 Schering Ag NEW PYRIDINE DERIVATIVES
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
DE2746244C2 (en) 1983-05-19
IE45805B1 (en) 1982-12-01
JPS5534132B2 (en) 1980-09-04
FR2367754A1 (en) 1978-05-12
PT67164A (en) 1977-11-01
SE437024B (en) 1985-02-04
CA1088945A (en) 1980-11-04
CH625511A5 (en) 1981-09-30
NL167434B (en) 1981-07-16
ATA745977A (en) 1979-09-15
DK461377A (en) 1978-04-19
YU40821B (en) 1986-06-30
NL167434C (en) 1981-12-16
FI62307C (en) 1982-12-10
FI62307B (en) 1982-08-31
BG28847A3 (en) 1980-07-15
IE45805L (en) 1978-04-18
DE2759927C2 (en) 1986-12-04
NO148453C (en) 1983-10-12
FR2367754B1 (en) 1982-07-09
DE2759542C2 (en) 1988-07-07
AT356136B (en) 1980-04-10
JPS5940388B2 (en) 1984-09-29
JPS5495575A (en) 1979-07-28
SE7711053L (en) 1978-04-19
AR220901A1 (en) 1980-12-15
JPS5495570A (en) 1979-07-28
YU244277A (en) 1982-08-31
AU504978B2 (en) 1979-11-01
PH15639A (en) 1983-03-11
MY8200157A (en) 1982-12-31
PT67164B (en) 1979-03-20
NO773548L (en) 1978-04-19
JPS5353653A (en) 1978-05-16
DE2759543C2 (en) 1987-04-09
NL7711358A (en) 1978-04-20
DD131931A5 (en) 1978-08-09
IL53094A0 (en) 1977-12-30
MX4899E (en) 1982-12-14
NZ185358A (en) 1979-06-08
HK53881A (en) 1981-11-13
DE2746244A1 (en) 1978-04-20
KE3167A (en) 1981-11-06
JPS607997B2 (en) 1985-02-28
FI773060A (en) 1978-04-19
GR70201B (en) 1982-08-31
LU78330A1 (en) 1979-06-01
AU2943177A (en) 1979-04-12
DK150302B (en) 1987-02-02
GB1566171A (en) 1980-04-30
ES463267A1 (en) 1978-07-16
NO148453B (en) 1983-07-04

Similar Documents

Publication Publication Date Title
DK150302C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF SPIRO-HYDANTOIN COMPOUNDS OR PHARMACOLOGICAL ACCEPTABLE BASES
DK142372C (en) PROCEDURE FOR THE PREPARATION OF ANDROSTAN-17-ON DERIVATIVES
DK30277A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED PHENYLAMIDINES
DK148477C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF TETRAHYDROPYRIDINYLIN DERIVATIVE OR ADDITIONAL SALTS THEREOF
DK146542C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF DAUNOSAMINYLANTHRACYCLIONS
DK46777A (en) METHOD FOR THE PREPARATION OF META-ARYLOXYBENZALDEHYDE
DK113476A (en) METHOD FOR THE PREPARATION OF AMOXICILLINTRIHYDRATE
DK244577A (en) PROCEDURE FOR THE PREPARATION OF HYDANTO INTERVENTIVES
DK178677A (en) PROCEDURE FOR THE PREPARATION OF ADENIN DERIVATIVES
DK271977A (en) PROCEDURE FOR THE PREPARATION OF DISPEPTIDE DERIVATIVES
DK339677A (en) PROCEDURE FOR THE PREPARATION OF 2-BENZYLPYRROLIDINES
DK145263C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF IMIDAZOTHIAZINES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
DK46577A (en) PROCEDURE FOR THE PREPARATION OF TETRAHYDROECHINOCANDIN DERIVATIVES
DK118177A (en) PROCEDURE FOR THE PREPARATION OF ISOBUTYRAMID DERIVATIVES
DK144377A (en) PROCEDURE FOR THE PREPARATION OF ACYLCYANIDES
DK88777A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED AZAPURINES
DK146718C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF BENZOBICYCLONONES
DK271377A (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED ARYLACETAMIDOCEPHALOSPORINES
DK216977A (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOBENZOXAZINES
DK144277A (en) PROCEDURE FOR THE PREPARATION OF ACYLCYANIDES
DK143752C (en) METHOD OF ANALOGUE FOR PREPARING PYRIDOBENZODIAZEPINON OR PHARMACOLOGICAL ACCEPTABLE SALTS THEREOF
DK264377A (en) PROCEDURE FOR THE PREPARATION OF 1ALFA-HYDROXYCHOLESTEROL DERIVATIVES
DK147280C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 4-AMINO-BENZO (B) BICYCLO (3,3,1) NONENDER DERIVATIVES
DK143750C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 1,2,3,4-TETRAHYDROISOQUINOLINES
DK196577A (en) PROCEDURE FOR THE PREPARATION OF CHOLECYSTOKININ-PANCREOZYMIN-OCTAPEPTIDAMIDE SULFATESTER

Legal Events

Date Code Title Description
PBP Patent lapsed